XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2025
Apr. 30, 2025
Current assets:    
Cash and cash equivalents $ 9,860 $ 6,715
Accounts receivable, net 2,207 1,191
Contract assets 555 1,088
Inventory 4,865 4,222
Other current assets 893 400
Total current assets 18,380 13,616
Property and equipment, net 4,703 3,444
Intangibles, net 3,456 3,490
Right-of-use assets, net 1,388 1,552
Restricted cash, long-term 154 154
Goodwill 8,537 8,537
Total assets 36,618 30,793
Current liabilities:    
Accounts payable 1,283 568
Earnout payable 250 300
Convertible notes payable (Note 13) 7,107
Derivative liability (Note 13) 570
Accrued expenses 1,293 1,271
Right-of-use liabilities, current portion 981 1,150
Contract liabilities 135
Total current liabilities 11,619 3,289
Deferred tax liability 203 203
Right-of-use liabilities, less current portion 606 649
Total liabilities 12,428 4,141
Commitments and contingencies (Note 14)
Shareholders’ Equity:    
Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding; 100,000 designated as Series A
Common stock, $0.001 par value; authorized 300,000,000 shares, issued 178,312,252 shares and 172,050,563 shares, respectively; outstanding 171,263,086 shares and 95,573,789 shares, respectively 178 172
Treasury stock, at cost; 787,477 and 787,477 shares, respectively (1,018) (1,018)
Additional paid-in capital 361,508 356,588
Accumulated deficit (336,478) (329,090)
Accumulated other comprehensive loss
Total shareholders’ equity 24,190 26,652
Total liabilities and shareholders’ equity $ 36,618 $ 30,793